Literature DB >> 7335960

Studies on the absorption and excretion of tripotassium dicitrato-bismuthate in man.

S P Lee.   

Abstract

In 8 volunteers blood and urine bismuth levels were detected after a 5-day course of tripotassium dicitrato-bismuthate and rose further with increasing dose. In 24 patients, blood and urine bismuth were measured on the last day of treatment. There was no significant difference (p greater than 0.2) in either blood or urine bismuth levels amongst patients treated for 4,5 or 6 weeks with colloidal bismuth. None of the blood level measurements exceeded 50 micrograms/l. Bismuth was slowly eliminated in the urine after stopping treatment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7335960

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  8 in total

1.  Anomalous short plasma elimination half life in a patient intoxicated with bismuth subcitrate.

Authors:  A J McLean; S Islam; J R Lambert
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

Review 2.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 3.  Pharmacokinetic considerations in the eradication of Helicobacter pylori.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

Review 4.  Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.

Authors:  A J Wagstaff; P Benfield; J P Monk
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

Review 5.  A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.

Authors:  A Hackelsberger; P Malfertheiner
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

6.  Absorption and elimination of bismuth from oral doses of tripotassium dicitrato bismuthate.

Authors:  P R Froomes; A T Wan; A C Keech; J J McNeil; A J McLean
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

7.  Uptake and subcellular localisation of bismuth in the gastrointestinal mucosa of rats after short term administration of colloidal bismuth subcitrate.

Authors:  D Stiel; D J Murray; T J Peters
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

Review 8.  Pharmacokinetics and toxicity of bismuth compounds.

Authors:  A Slikkerveer; F A de Wolff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.